Previous Article | Next Article 
Molecular and Cellular Biology, July 2006, p. 5086-5095, Vol. 26, No. 13
0270-7306/06/$08.00+0 doi:10.1128/MCB.02380-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis
Joan J. Bech-Serra,2
Belén Santiago-Josefat,2
Cary Esselens,2
Paul Saftig,3
José Baselga,2
Joaquín Arribas,2* and
Francesc Canals1,2
Proteomics Laboratory,1
Medical Oncology Research Program, Vall d'Hebron University Hospital Research Institute, Universitat Autonoma de Barcelona, 08035 Barcelona, Spain,2
Institute of Biochemistry, University of Kiel, D-24118 Kiel, Germany3
Received 14 December 2005/
Returned for modification 18 January 2006/
Accepted 7 April 2006
In contrast with the early view of metalloproteases as simple extracellular matrix-degrading entities, recent findings show that they are highly specific modulators of different signaling pathways involved, positively or negatively, in tumor development. Thus, before considering a given metalloprotease a therapeutic target, it seems advisable to characterize its function by identifying its repertoire of substrates. Here, we present a proteomic approach to identify ADAM17 substrates by difference gel electrophoresis. We found that the shedding of the extracellular domain of the transferrin receptor and those of two cell-cell adhesion molecules, activated leukocyte cell adhesion molecule (ALCAM) and desmoglein 2 (Dsg-2), is increased in cells overexpressing ADAM17. Genetic evidence shows that while ADAM17 is responsible for the shedding of ALCAM, both ADAM17 and ADAM10 can act on Dsg-2. Activation of the epidermal growth factor receptor leads to the upregulation of the shedding of Dsg-2 and to the concomitant upregulation of ADAM17, but not ADAM10, supporting the ability of overexpressed ADAM17 to shed Dsg-2. These results unveil a role of ADAM10 and ADAM17 in the shedding of cell-cell adhesion molecules. Since loss of cell adhesion is an early event in tumor development, these results suggest that ADAM17 is a useful target in anticancer therapy.
* Corresponding author. Mailing address: Medical Oncology Research Program, Vall d'Hebron University Hospital Research Institute, 08035 Barcelona, Spain. Phone: 34 93 274 6026. Fax: 34 93 274 6026. E-mail: jarribas{at}ir.vhebron.net.
Supplemental material for this article may be found at http://mcb.asm.org/.
Molecular and Cellular Biology, July 2006, p. 5086-5095, Vol. 26, No. 13
0270-7306/06/$08.00+0 doi:10.1128/MCB.02380-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mruk, D. D., Silvestrini, B., Cheng, C. Y.
(2008). Anchoring Junctions As Drug Targets: Role in Contraceptive Development. Pharmacol. Rev.
60: 146-180
[Abstract]
[Full Text]
-
van Kilsdonk, J. W.J., Wilting, R. H., Bergers, M., van Muijen, G. N.P., Schalkwijk, J., van Kempen, L. C.L.T., Swart, G. W.M.
(2008). Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion Molecule. Cancer Res.
68: 3671-3679
[Abstract]
[Full Text]
-
Rosso, O., Piazza, T., Bongarzone, I., Rossello, A., Mezzanzanica, D., Canevari, S., Orengo, A. M., Puppo, A., Ferrini, S., Fabbi, M.
(2007). The ALCAM Shedding by the Metalloprotease ADAM17/TACE Is Involved in Motility of Ovarian Carcinoma Cells. Mol Cancer Res
5: 1246-1253
[Abstract]
[Full Text]
-
Nava, P., Laukoetter, M. G., Hopkins, A. M., Laur, O., Gerner-Smidt, K., Green, K. J., Parkos, C. A., Nusrat, A.
(2007). Desmoglein-2: A Novel Regulator of Apoptosis in the Intestinal Epithelium. Mol. Biol. Cell
18: 4565-4578
[Abstract]
[Full Text]
-
Gavert, N., Sheffer, M., Raveh, S., Spaderna, S., Shtutman, M., Brabletz, T., Barany, F., Paty, P., Notterman, D., Domany, E., Ben-Ze'ev, A.
(2007). Expression of L1-CAM and ADAM10 in Human Colon Cancer Cells Induces Metastasis. Cancer Res.
67: 7703-7712
[Abstract]
[Full Text]
-
Lynch, C. C., Vargo-Gogola, T., Martin, M. D., Fingleton, B., Crawford, H. C., Matrisian, L. M.
(2007). Matrix Metalloproteinase 7 Mediates Mammary Epithelial Cell Tumorigenesis through the ErbB4 Receptor. Cancer Res.
67: 6760-6767
[Abstract]
[Full Text]
-
Santiago-Josefat, B., Esselens, C., Bech-Serra, J. J., Arribas, J.
(2007). Post-transcriptional Up-regulation of ADAM17 upon Epidermal Growth Factor Receptor Activation and in Breast Tumors. J. Biol. Chem.
282: 8325-8331
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.